Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury

American Journal of Pathology

Volumn 173, Issue 4, 2008, Pages 1100-1112

  Isenberg, Jeff S ^a   Maxhimer, Justin B ^a   Hyodo, Fuminori ^a   Pendrak, Michael L ^a   Ridnour, Lisa A ^a   DeGraff, William G ^a   Tsokos, Maria ^a   Wink, David A ^a   Roberts, David D ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIGEN; THROMBOSPONDIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; BONE MARROW; CELL DEATH; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PROTECTION; RADIOSENSITIVITY; RADIOSENSITIZATION; TISSUE PERFUSION;

EID: 53149130570     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080237     Document Type: Article

References (48)

1. Chapman JD: Single-hit mechanism of tumour cell killing by radiation. Int J Radiat Biol 2003, 79:71-81
2. Prise KM, Schettino G, Folkard M, Held KD: New insights on cell death from radiation exposure. Lancet Oncol 2005, 6:520-528
3. Purdy JA: From new frontiers to new standards of practice: advances in radiotherapy planning and delivery. Front Radiat Ther Oncol 2007, 40:18-39
4. Poggi MM, Coleman CN, Mitchell JB: Sensitizers and protectors of radiation and chemotherapy. Curr Probl Cancer 2001, 25:334-411
5. Karagiannis TC, El-Osta A: Modulation of cellular radiation responses by histone deacetylase inhibitors. Oncogene 2006, 25:3885-3893
6. McKenna WG, Muschel RJ, Gupta AK, Hahn SM, Bernhard EJ: The RAS signal transduction pathway and its role in radiation sensitivity. Oncogene 2003, 22:5866-5875
7. Cotrim AP, Hyodo F, Matsumoto K, Sowers AL, Cook JA, Baum BJ, Krishna MC, Mitchell JB: Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging. Clin Cancer Res 2007, 13:4928-4933
8. Freeman SL, MacNaughton WK: Nitric oxide inhibitable isoforms of adenylate cyclase mediate epithelial secretory dysfunction following exposure to ionising radiation. Gut 2004, 53:214-221
9. Leach JK, Black SM, Schmidt-Ullrich RK, Mikkelsen RB: Activation of constitutive nitric-oxide synthase activity is an early signaling event induced by ionizing radiation. J Biol Chem 2002, 277:15400-15406
10. Zhong GZ, Chen FR, Bu DF, Wang SH, Pang YZ, Tang CS: Cobalt-60 gamma radiation increased the nitric oxide generation in cultured rat vascular smooth muscle cells. Life Sci 2004, 74:3055-3063
11. Liebmann J, DeLuca AM, Coffin D, Keefer LK, Venzon D, Wink DA, Mitchell JB: In vivo radiation protection by nitric oxide modulation. Cancer Res 1994, 54:3365-3368
12. Ohta S, Matsuda S, Gunji M, Kamogawa A: The role of nitric oxide in radiation damage. Biol Pharm Bull 2007, 30:1102-1107
13. Cook T, Wang Z, Alber S, Liu K, Watkins SC, Vodovotz Y, Billiar TR, Blumberg D: Nitric oxide and ionizing radiation synergistically promote apoptosis and growth inhibition of cancer by activating p53. Cancer Res 2004, 64:8015-8021
14. Epperly MW, Cao S, Zhang X, Franicola D, Shen H, Greenberger EE, Epperly LD, Greenberger JS: Increased longevity of hematopoiesis in continuous bone marrow cultures derived from NOS1 (nNOS, mt-NOS) homozygous recombinant negative mice correlates with radioresistance of hematopoietic and marrow stromal cells. Exp Hematol 2007, 35:137-145
15. Isenberg JS, Ridnour LA, Perruccio EM, Espey MG, Wink DA, Roberts DD: Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner. Proc Natl Acad Sci USA 2005, 102:13141-13146
16. Isenberg JS, Wink DA, Roberts DD: Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses. Cardiovasc Res 2006, 71:785-793
17. Isenberg JS, Ridnour LA, Dimitry J, Frazier WA, Wink DA, Roberts DD: CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 2006, 281:26069-26080
18. Isenberg JS, Hyodo F, Pappan LK, Abu-Asab M, Tsokos M, Krishna MC, Frazier WA, Roberts DD: Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia. Arterioscler Thromb Vasc Biol 2007, 27:2582-2588
19. Isenberg JS, Hyodo F, Matsumoto K, Romeo MJ, Abu-Asab M, Tsokos M, Kuppusamy P, Wink DA, Krishna MC, Roberts DD: Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation. Blood 2007, 109:1945-1952
20. Isenberg JS, Romeo MJ, Abu-Asab M, Tsokos M, Oldenborg A, Pappan L, Wink DA, Frazier WA, Roberts DD: Increasing survival of ischemic tissue by targeting CD47. Circ Res 2007, 100:712-720
21. Manna PP, Dimitry J, Oldenborg PA, Frazier WA: CD47 augments Fas/CD95-mediated apoptosis. J Biol Chem 2005, 280:29637-29644
22. Bras M, Yuste VJ, Roue G, Barbier S, Sancho P, Virely C, Rubio M, Baudet S, Esquerda JE, Merle-Beral H, Sarfati M, Susin SA: Drp1 mediates caspase-independent type III cell death in normal and leukemic cells. Mol Cell Biol 2007, 27:7073-7088
23. Flanders KC, Sullivan CD, Fujii M, Sowers A, Anzano MA, Arabshahi A, Major C, Deng C, Russo A, Mitchell JB, Roberts AB: Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol 2002, 160:1057-1068
24. Flanders KC, Major CD, Arabshahi A, Aburime EE, Okada MH, Fujii M, Blalock TD, Schultz GS, Sowers A, Anzano MA, Mitchell JB, Russo A, Roberts AB: Interference with transforming growth factor-beta/Smad3 signaling results in accelerated healing of wounds in previously irradiated skin. Am J Pathol 2003, 163:2247-2257
25. Yano K, Brown LF, Lawler J, Miyakawa T, Detmar M: Thrombospondin-1 plays a critical role in the induction of hair follicle involution and vascular regression during the catagen phase. J Invest Dermatol 2003, 120:14-19
26. Prithivirajsingh S, Story MD, Bergh SA, Geara FB, Ang KK, Ismail SM, Stevens CW, Buchholz TA, Brock WA: Accumulation of the common mitochondrial DNA deletion induced by ionizing radiation. FEBS Lett 2004, 571:227-232
27. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N: Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998, 93:1159-1170
28. Wang S, Wu Z, Sorenson CM, Lawler J, Sheibani N: Thrombospondin-1- deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration. Dev Dyn 2003, 228:630-642
29. Bornstein P, Agah A, Kyriakides TR: The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int J Biochem Cell Biol 2004, 36:1115-1125
30. Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO: Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 1998, 101:982-992
31. Mazur L, Augustynek A, Halicka HD, Deptala A: Induction of apoptosis in bone marrow cells after treatment of mice with WR-2721 and gamma-rays: relationship to the cell cycle. Cell Biol Toxicol 2003, 19:13-27
32. Rodemann HP, Blaese MA: Responses of normal cells to ionizing radiation. Semin Radiat Oncol 2007, 17:81-88
33. Weinstat-Saslow DL, Zabrenetzky VS, VanHoutte K, Frazier WA, Roberts DD, Steeg PS: Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 1994, 54:6504-6511
34. Isenberg JS, Hyodo F, Ridnour LA, Shannon CS, Wink DA, Krishna MC, Roberts DD: Thrombospondin-1 and vasoactive agents indirectly alter tumor blood flow. Neoplasia 2008, 10:886-896
35. Lawler J, Miao WM, Duquette M, Bouck N, Bronson RT, Hynes RO: Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice. Am J Pathol 2001, 159:1949-1956
36. Rofstad EK, Henriksen K, Galappathi K, Mathiesen B: Antiangiogenic treatment with thrombospondin-1 enhances primary tumor radiation response and prevents growth of dormant pulmonary micrometastases after curative radiation therapy in human melanoma xenografts. Cancer Res 2003, 63:4055-4061
37. Culp WD, Tsagozis P, Burgio M, Russell P, Pisa P, Garland D: Interference of macrophage migration inhibitory factor expression in a mouse melanoma inhibits tumor establishment by up-regulating thrombospondin-1. Mol Cancer Res 2007, 5:1225-1231
38. Lindberg FP, Bullard DC, Caver TE, Gresham HD, Beaudet AL, Brown EJ: Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 1996, 274:795-798
39. Li Z, Calzada MJ, Sipes JM, Cashel JA, Krutzsch HC, Annis DS, Mosher DF, Roberts DD: Interactions of thrombospondins with alpha4beta1 integrin and CD47 differentially modulate T cell behavior. J Cell Biol 2002, 157:509-519
40. Brush J, Lipnick SL, Phillips T, Sitko J, McDonald JT, McBride WH: Molecular mechanisms of late normal tissue injury. Semin Radiat Oncol 2007, 17:121-130
41. Murphy-Ullrich JE, Poczatek M: Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev 2000, 11:59-69
42. Belmadani S, Bernal J, Wei CC, Pallero MA, Dell'italia L, Murphy-Ullrich JE, Berecek KH: A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II. Am J Pathol 2007, 171:777-789
43. Gao AG, Lindberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA: Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 1996, 271:21-24
44. Lamy L, Foussat A, Brown EJ, Bornstein P, Ticchioni M, Bernard A: Interactions between CD47 and thrombospondin reduce inflammation. J Immunol 2007, 178:5930-5939
45. Carlson CB, Lawler J, Mosher DF: Thrombospondins: from structure to therapeutics: structures of thrombospondins. Cell Mol Life Sci 2008, 65:672-686
46. Komarova EA, Kondratov RV, Wang K, Christov K, Golovkina TV, Goldblum JR, Gudkov AV: Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastrointestinal syndrome in mice. Oncogene 2004, 23:3265-3271
47. Epperly MW, Goff JP, Zhang X, Niu Y, Shields DS, Wang H, Shen H, Franicola D, Bahnson AB, Nie S, Greenberger EE, Greenberger JS: Increased radioresistance, g(2)/m checkpoint inhibition, and impaired migration of bone marrow stromal cell lines derived from Smad3(-/-) mice. Radiat Res 2006, 165:671-677
48. Takai H, Naka K, Okada Y, Watanabe M, Harada N, Saito S, Anderson CW, Appella E, Nakanishi M, Suzuki H, Nagashima K, Sawa H, Ikeda K, Motoyama N: Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J 2002, 21:5195-5205